These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1541384)

  • 1. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control.
    Schnack C; Bauer I; Pregant P; Hopmeier P; Schernthaner G
    Diabetologia; 1992 Jan; 35(1):77-9. PubMed ID: 1541384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy.
    Eibl NL; Kopp HP; Nowak HR; Schnack CJ; Hopmeier PG; Schernthaner G
    Diabetes Care; 1995 Feb; 18(2):188-92. PubMed ID: 7729296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
    Drenthen LCA; de Baaij JHF; Rodwell L; van Herwaarden AE; Tack CJ; de Galan BE
    Diabetologia; 2024 Jan; 67(1):52-61. PubMed ID: 37922013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.
    Guerrero-Romero F; Rodríguez-Morán M
    J Diabetes Complications; 2000; 14(5):272-6. PubMed ID: 11113690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.
    Wolffenbuttel BH; Leurs PB; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC
    Diabet Med; 1993 Jun; 10(5):427-30. PubMed ID: 8334821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics.
    Purvis JR; Cummings DM; Landsman P; Carroll R; Barakat H; Bray J; Whitley C; Horner RD
    Arch Fam Med; 1994 Jun; 3(6):503-8. PubMed ID: 8081529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study.
    Aas AM; Bergstad I; Thorsby PM; Johannesen O; Solberg M; Birkeland KI
    Diabet Med; 2005 Mar; 22(3):316-22. PubMed ID: 15717881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
    Rosenstock J; Einhorn D; Hershon K; Glazer NB; Yu S;
    Int J Clin Pract; 2002 May; 56(4):251-7. PubMed ID: 12074206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.
    Wulffelé MG; Kooy A; de Zeeuw D; Stehouwer CD; Gansevoort RT
    J Intern Med; 2004 Jul; 256(1):1-14. PubMed ID: 15189360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus.
    Corica F; Allegra A; Di Benedetto A; Giacobbe MS; Romano G; Cucinotta D; Buemi M; Ceruso D
    Magnes Res; 1994 Mar; 7(1):43-7. PubMed ID: 8054260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum magnesium levels in non-diabetic offspring of patients with Type 2 diabetes mellitus.
    Maltezos E; Papazoglou D; Exiara T; Kambouromiti G; Antonoglou C
    Diabetes Nutr Metab; 2004 Feb; 17(1):12-6. PubMed ID: 15163119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.
    Rivellese AA; Patti L; Romano G; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4188-92. PubMed ID: 11095452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients.
    de Valk HW; Verkaaik R; van Rijn HJ; Geerdink RA; Struyvenberg A
    Diabet Med; 1998 Jun; 15(6):503-7. PubMed ID: 9632126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum magnesium and atherogenic lipid fractions in type II diabetic patients of Lahore, Pakistan.
    Rasheed H; Elahi S; Ajaz H
    Biol Trace Elem Res; 2012 Aug; 148(2):165-9. PubMed ID: 22351157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.